Dennis M. Lanfear
Known title: President & CEOCIK: 0001420822
Associated companies
Transaction History
| CHRS | ▲ Buy | Grant | 375,000 | $0 | 1/23/2026 | View on chart |
| CHRS | ▼ Sell | Tax Withholding | 11,839 | $18K | 1/20/2026 | View on chart |
| CHRS | ▼ Sell | Tax Withholding | 11,810 | $16K | 1/20/2025 | View on chart |
| CHRS | ▼ Sell | Tax Withholding | 11,810 | $20K | 1/4/2025 | View on chart |
| CHRS | ▼ Sell | Tax Withholding | 11,218 | $27K | 1/20/2024 | View on chart |
| CHRS | ▼ Sell | Tax Withholding | 11,781 | $34K | 1/4/2024 | View on chart |
| CHRS | ▲ Buy | Option Exercise | 41,000 | $58K | 11/22/2023 | View on chart |
| CHRS | ▲ Buy | Option Exercise | 258,940 | $367K | 11/22/2023 | View on chart |
| CHRS | ▼ Sell | Open Market | 223,100 | $450K | 11/22/2023 | View on chart |
| CHRS | ▲ Buy | Grant | 86,250 | $0 | 1/20/2023 | View on chart |
| CHRS | ▼ Sell | Tax Withholding | 10,905 | $108K | 1/4/2023 | View on chart |
| CHRS | ▼ Sell | Gift | 4,000 | $0 | 12/30/2022 | View on chart |
| CHRS | ▲ Buy | Grant | 86,250 | $0 | 1/4/2022 | View on chart |
| CHRS | ▼ Sell | Gift | 10,000 | $0 | 11/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
CHRS Retains Oppenheimer to Market Legacy Biosimilar Assets
Coherus Oncology announced that it has retained Oppenheimer & Co. to market its legacy biosimilar assets. The move aims to increase visibility and potential partnerships for older products in its pipeline. The stock is currently near a long‑standing support level, which may draw attention as the company pursues these marketing efforts.
CHRS Retains Oppenheimer to Market Legacy Biosimilar Assets. Coherus Oncology announced that it has retained Oppenheimer & Co. to market its legacy biosimilar assets. The move aims to increase visibility and potential partnerships for older products in its pipeline. The stock is currently near a long‑standing support level, which may draw attention as the company pursues these marketing efforts.